Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Motoshi Ichikawa

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
International Journal of Hematology|February 25, 2011
Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemiaTetsuichi Yoshizato, Yasuhito Nannya, Yumiko Yoshiki, et al.
Journal of the Neurological Sciences|January 13, 2012
Fludarabine may overcome resistance to rituximab in IgM-related neuropathyJunji Koya, Atsushi Iwata, Fumihiko Nakamura, et al.
Journal of Forensic Sciences|January 23, 2018
Sudden Death from Cardiopulmonary Arrest on Arrival of a Patient with Pulmonary Tuberculosis: A Case Diagnosed by Postmortem CT and AutopsyDaizo Yaguchi, Motoshi Ichikawa, Noriko Inoue, et al.
Case Reports in Oncology|November 25, 2015
An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on ImagingDaizo Yaguchi, Motoshi Ichikawa, Noriko Inoue, et al.
Oncogene|April 20, 2002
The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBPKoji Izutsu, Mineo Kurokawa, Yoichi Imai, et al.
Cell Stem Cell|August 7, 2008
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cellsSusumu Goyama, Go Yamamoto, Munetake Shimabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2013
Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemiaHiromitsu Iizuka, Akihide Yoshimi, Go Yamamoto, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2017
Nonmyelomatous Ascites Resulting from the Increased Secretion of Vascular Endothelial Growth Factor in Multiple MyelomaHiroaki Maki, Yasuhito Nannya, Yoichi Imai, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemiaYumiko Yoshiki, Takashi Asai, Motoshi Ichikawa, et al.
Blood|December 31, 2010
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cellsShunya Arai, Akihide Yoshimi, Munetake Shimabe, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
International Journal of Hematology|February 25, 2011
Nilotinib-induced hypothyroidism in a patient with chronic myeloid leukemiaTetsuichi Yoshizato, Yasuhito Nannya, Yumiko Yoshiki, et al.
Journal of the Neurological Sciences|January 13, 2012
Fludarabine may overcome resistance to rituximab in IgM-related neuropathyJunji Koya, Atsushi Iwata, Fumihiko Nakamura, et al.
Journal of Forensic Sciences|January 23, 2018
Sudden Death from Cardiopulmonary Arrest on Arrival of a Patient with Pulmonary Tuberculosis: A Case Diagnosed by Postmortem CT and AutopsyDaizo Yaguchi, Motoshi Ichikawa, Noriko Inoue, et al.
Case Reports in Oncology|November 25, 2015
An Autopsied Case of Malignant Sarcomatoid Pleural Mesothelioma in Which Chest Pain Developed Several Months Earlier without Abnormality on ImagingDaizo Yaguchi, Motoshi Ichikawa, Noriko Inoue, et al.
Oncogene|April 20, 2002
The t(3;21) fusion product, AML1/Evi-1 blocks AML1-induced transactivation by recruiting CtBPKoji Izutsu, Mineo Kurokawa, Yoichi Imai, et al.
Cell Stem Cell|August 7, 2008
Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cellsSusumu Goyama, Go Yamamoto, Munetake Shimabe, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|June 4, 2013
Effective azacitidine treatment for myelodysplastic syndrome transformed from essential thrombocythemiaHiromitsu Iizuka, Akihide Yoshimi, Go Yamamoto, et al.
Internal Medicine (Tokyo, Japan)|November 21, 2017
Nonmyelomatous Ascites Resulting from the Increased Secretion of Vascular Endothelial Growth Factor in Multiple MyelomaHiroaki Maki, Yasuhito Nannya, Yoichi Imai, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2011
A case of myeloid sarcoma with correlation to JAK2V617F mutation, complicated by myelofibrosis and secondary acute myeloid leukemiaYumiko Yoshiki, Takashi Asai, Motoshi Ichikawa, et al.
Blood|December 31, 2010
Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cellsShunya Arai, Akihide Yoshimi, Munetake Shimabe, et al.
Pageof 10